Blood eosinophils associate with reduced lung function growth in adolescent asthmatics.

Authors:
Koefoed HJL; Gehring U; Vonk JM; Koppelman GH.

Journal:
Clin Exp Allergy

Publication Year: 2021

DOI:
10.1111/cea.13818

PMCID:
PMC8048657

PMID:
33386641

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Exp Allergy

Abbreviation: Clin Exp Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anaphylaxis in Brazil between 2011 and 2019.
Tanno LK; Molinari N; Annesi-Maesano I and 2 more (2022) - Transparency Score: 3/6
Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with na…
Eide JG; Wu J; Stevens WW and 16 more (2022) - Transparency Score: 3/6
Association between allergic sensitization and intestinal parasite infection in schoolchildren in G…
Brandt O; Wegenstein B; Müller I and 12 more (2022) - Transparency Score: 3/6
Burden of allergic disease among ethnic minority groups in high-income countries.
Jones CJ; Paudyal P; West RM and 5 more (2022) - Transparency Score: 2/6
Efficacy of N-acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctiv…
de Blay F; Gherasim A; Domis N and 2 more (2022) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST Dr. G. H. Koppelman reports grants from Lung Foundation of the Netherlands, during the conduct of the study; grants from Lung Foundation of the Netherlands, TEVA, the Netherlands, GSK, Ubbo Emmius Foundation, TETRI Foundation, Vertex, outside the submitted work; GHK has participated in advisory board meetings to GSK and PURE‐IMS."

Evidence found in paper:

"The PIAMA study has received funding from the Netherlands Organization for Health Research and Development, the Netherlands Organization for Scientific Research, the Lung Foundation Netherlands (previously Asthma Fund), the Netherlands Ministry of Spatial Planning, Housing, and the Environment, and the Netherlands Ministry of Health, Welfare, and Sport."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025